This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)
C3_RETROPERITONEUM_PERITONEUM_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
581 |
4. Check minimum number of eventsNone |
581 |
5. Include endpointsNone |
581 |
6. Filter based on genotype QC (FinnGen only) |
581 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 581 | 414 | 167 |
| Unadjusted period prevalence (%) | 0.12 | 0.14 | 0.07 |
| Median age at first event (years) | 66.69 | 66.20 | 67.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 213
- Matched controls
- 2130
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
332.8
128.7
119
8
130
Kela drug reimbursment
Malignant tumour
+∞
112.8
98
*
A03FA01
ATC
metoclopramide; systemic, rectal
26.7
89.8
142
148
WX302
NOMESCO Finland
Thoracal epidural anesthesy
106.7
87.6
92
15
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
72.1
65
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
67.3
61
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
843.2
65.6
61
*
JN4BD
NOMESCO Finland
Extensive body CT
33.4
65.2
87
43
A04AA01
ATC
ondansetron; systemic, rectal
41.9
64.0
80
30
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
29.1
63.9
89
51
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
58.0
53
*
JAL30
NOMESCO Finland
Omentectomy
188.6
55.9
56
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
52.3
48
*
8461/3-C48.2
ICD-O-3
High grade serous carcinoma of peritoneum, NOS
+∞
51.1
47
*
Z51.5
ICD-10 Finland
Palliative care
45.8
49.4
60
18
B01AB10
ATC
tinzaparin; parenteral
23.1
47.9
71
45
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
47.7
44
*
R18
ICD-10 Finland
Ascites
72.0
44.7
50
9
L03AA13
ATC
pegfilgrastim; parenteral
+∞
44.3
41
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
43.2
40
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
43.2
40
*
N02AA05
ATC
oxycodone; systemic
10.6
39.9
87
130
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
39.9
37
*
L03AA02
ATC
filgrastim; parenteral
+∞
39.9
37
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
35.4
33
*
JN4AD
NOMESCO Finland
Body CT examination
22.9
34.4
50
28
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
25.4
34.1
48
24
A04AA55
ATC
palonosetron, combinations; systemic
+∞
28.8
27
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
28.8
27
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
28.8
27
*
WX402
NOMESCO Finland
General anaesthesia
8.1
28.4
71
124
TPH07
NOMESCO Finland
Cathetrisation of artery
8.6
27.8
66
106
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
27.7
26
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
27.7
26
*
B01AB05
ATC
enoxaparin; parenteral
5.1
27.0
118
415
JAL00
NOMESCO Finland
Biopsy of peritoneum
106.9
26.3
28
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.2
26.0
107
348
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
281.7
25.2
25
*
WW500
NOMESCO Finland
Blood transfusion
16.7
24.8
40
29
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.7
24.5
62
108
L02BG04
ATC
letrozole; oral
76.8
24.4
27
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
24.4
23
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
24.4
23
*
LCD00
NOMESCO Finland
Hysterectomy
12.3
23.7
44
44
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.5
23.7
42
38
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
30.0
23.4
31
12
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
+∞
23.4
22
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
256.4
23.1
23
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
22.3
21
*
8461/3-C48.1
ICD-O-3
High grade serous carcinoma of specified parts of peritoneum
+∞
22.3
21
*
ZXE20
NOMESCO Finland
More than three and less than five hours
6.3
21.8
64
135
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
21.2
20
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
85.7
21.1
23
*
JAH00
NOMESCO Finland
Laparotomy
25.6
21.0
29
13
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
23.7
20.6
29
14
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
40.2
20.3
25
7
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
20.1
19
*
JAH01
NOMESCO Finland
Laparoscopy
14.8
19.7
33
26
JEA00
NOMESCO Finland
Appendectomy
9.3
19.2
41
53
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.7
18.8
74
215
XX3DW
NOMESCO Finland
Time consuming IT work
11.1
18.2
35
37
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
18.0
17
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
18.0
17
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
18.0
17
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.9
17.8
26
14
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
16.9
16
*
A04AD12
ATC
aprepitant; systemic
+∞
16.9
16
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.1
16.0
24
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
15.8
123
617
C48.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum
+∞
15.8
15
*
A79
ICPC
Malignancy NOS
+∞
15.8
15
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.8
15.8
29
28
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.2
15.6
31
35
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
19.7
15.5
23
13
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
15.3
82
306
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
14.8
14
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
14.8
14
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
14.8
14
*
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
14.8
14
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
160.6
14.7
15
*
ZX120
NOMESCO Finland
Intravenous
6.2
14.4
40
76
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
80.4
13.8
15
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
13.7
13
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
13.7
13
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
13.7
13
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
13.7
13
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
13.7
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
20.7
13.2
19
10
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.3
13.1
82
338
JN3AD
NOMESCO Finland
Abdominal CT examination
6.3
13.0
35
64
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
12.6
12
*
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
12.6
12
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
12.6
12
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
+∞
12.6
12
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
19.5
12.3
18
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
12.2
48
134
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
12.1
43
108
R50.9
ICD-10 Finland
Fever, unspecified
4.9
12.0
41
99
WZC30
NOMESCO Finland
Teaching
5.2
11.6
37
83
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
11.6
11
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
11.6
11
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
11.6
11
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
11.6
11
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
16.2
11.5
18
12
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
37.3
11.4
14
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
7.3
10.9
26
40
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
10.0
10.8
21
23
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.3
10.7
17
12
S18
ICPC
Laceration/cut
2.7
10.6
106
575
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
115.5
10.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
115.5
10.5
11
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.5
10.5
19
18
C48.2
ICD-10 Finland
Malignant neoplasm: Peritoneum, unspecified
+∞
10.5
10
*
C48.29
ICD-10 Finland
Malignant tumor in unspecified localization in peritoneum other or unspecified histology
+∞
10.5
10
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
+∞
10.5
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
10.4
64
256
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.1
10.4
17
13
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
42.2
10.1
12
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
10.0
95
496
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
10.3
10.0
19
20
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
57.7
9.7
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
104.5
9.5
10
*
KAC00
NOMESCO Finland
Nephrectomy
104.5
9.5
10
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.4
9
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
9.4
9
*
C48.1
ICD-10 Finland
Malignant neoplasm: Specified parts of peritoneum
+∞
9.4
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
9.4
9
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
X77
ICPC
Malignant neopl genital female other
+∞
9.4
9
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.3
8.9
27
57
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
8.9
49
179
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
52.2
8.8
10
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
17.2
8.7
13
8
HA1AA
NOMESCO Finland
X-ray mammography
7.2
8.6
20
30
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
28.8
8.6
11
*
JFB30
NOMESCO Finland
Right hemicolectomy
28.8
8.6
11
*
WF002
NOMESCO Finland
Radical radiotherapy
28.8
8.6
11
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
93.6
8.5
9
*
C48.80
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum without histology
+∞
8.4
8
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.4
8
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
8.4
8
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
8.4
8
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
8.4
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.4
8
*
A06AH03
ATC
naloxegol; oral
+∞
8.4
8
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.4
8
*
JFB00
NOMESCO Finland
Partial resection of small intestine
15.3
8.3
13
9
N02BE01
ATC
paracetamol; systemic, rectal
3.7
8.3
196
1615
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.4
8.2
21
36
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
18.0
8.2
12
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
7.8
91
512
Z51.88
ICD-10 Finland
Other specified medical care
10.6
7.7
14
14
JFF10
NOMESCO Finland
Loop enterostomy
82.9
7.5
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
82.9
7.5
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
82.9
7.5
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.0
7.4
29
80
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.9
7.4
14
15
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
7.3
7
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.3
7
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.0
7.3
17
26
D70.82
ICD-10 Finland
Drug-induced neutropenia
31.2
7.2
9
*
A02BC02
ATC
pantoprazole; systemic
2.3
7.1
152
1111
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.6
7.1
32
100
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
7.1
94
554
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
8.0
7.0
15
20
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
17.4
6.8
10
6
JFB46
NOMESCO Finland
Resection of sigmoid colon
17.4
6.8
10
6
SPAT1109
SPAT
Analgesia with portable analgesic pump
71.9
6.5
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
71.9
6.5
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
71.9
6.5
7
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
71.9
6.5
7
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
14.9
6.5
10
7
B03XA02
ATC
darbepoetin alfa; parenteral
14.9
6.5
10
7
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.6
6.4
13
16
N02AX02
ATC
tramadol; systemic, rectal
2.1
6.3
103
655
TJA10
NOMESCO Finland
Laparocentesis
+∞
6.3
6
*
1510
Kela drug reimbursment
Niraparib
+∞
6.3
6
*
8460/3-C48.2
ICD-O-3
Low grade serous carcinoma of peritoneum, NOS
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
D74
ICPC
Malignant neoplasm stomach
+∞
6.3
6
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
6.3
6
*
3009
Kela drug reimbursment
Niraparib
+∞
6.3
6
*
JFB43
NOMESCO Finland
Left hemicolectomy
27.6
6.3
8
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
27.6
6.3
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
260
185
24.63
306.18
17.8
1.5
u/ml
245.9
24.3
6.34
255
177
(4035726)
206
127
24.58
257.22
1.5
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
251
252
16.78
239.37
3.1
1.4
ug/l
3.6
4.0
0.10
172
193
(4281824)
110
24
56.30
191.25
1.4
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
137
105
16.77
149.46
2.4
1.8
u/ml
203.3
75.1
0.50
114
84
(3023368) Bacteria identified in Blood by Culture
323
1127
5.20
86.62
5.1
3.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
221
634
5.01
73.68
5.4
2.4
mmol/l
0.8
0.8
4.08
214
575
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
453
2292
5.43
70.46
14.7
3.6
umol/l
9.7
11.8
3.07
446
2141
(3024561) Albumin [Mass/volume] in Serum or Plasma
410
1987
4.61
65.72
9.5
3.4
g/l
32.0
35.5
19.30
397
1828
(3044640) Blood type and Crossmatch panel - Blood
311
1291
4.03
60.81
3.6
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
398
1997
4.15
58.01
6.3
3.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
265
1020
3.94
57.12
3.5
1.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
267
1048
3.86
55.63
7.4
3.3
%
93.5
89.7
1.95
262
1017
(3013650) Neutrophils [#/volume] in Blood by Automated count
448
2543
4.33
52.20
26.7
6.3
e9/l
4.1
4.2
0.84
399
2199
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
143
388
4.56
49.19
2.7
1.9
u/l
49.0
33.6
0.44
122
317
(3003396) Base excess in Arterial blood by calculation
166
523
4.04
46.49
8.7
7.0
mmol/l
0.6
1.5
2.32
145
417
(3000991) Gas panel - Venous blood
130
345
4.57
45.78
9.2
8.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
132
368
4.35
43.45
8.7
7.2
mmol/l
1.1
1.4
5.07
132
357
(40768804) Tissue Pathology biopsy report
312
1540
3.22
42.16
2.8
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
125
347
4.32
41.25
2.1
1.9
g/l
0.2
0.2
0.65
111
316
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
147
462
3.92
40.84
2.9
2.2
umol/l
7.7
6.7
0.27
132
391
(3002256) Pathology report gross observation
117
317
4.37
39.78
1.4
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
30
16
19.72
38.10
1.1
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
348
1903
3.07
37.99
6.6
9.3
inr
1.1
1.3
2.53
77
537
(3042936) Bacteria identified in Isolate by Culture
173
639
3.43
37.31
1.9
1.9
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
41
6
73.26
36.46
1.2
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
233
1047
3.05
35.82
19.4
4.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
124
5.88
34.34
3.2
3.1
u/ml
0.4
0.4
0.15
32
74
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
87
219
4.50
32.23
10.1
10.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
364
2169
2.82
31.67
9.0
5.3
mmol/l
1.2
1.2
6.75
353
1898
(3044007) Cell count panel - Peritoneal fluid
37
9
43.82
30.29
1.2
2.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
283
1514
2.69
30.03
6.5
5.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
30
26
12.11
29.36
1.6
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
97
288
3.84
28.62
1.6
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
286
1581
2.59
27.79
8.6
2.0
mmol/l
2.3
2.4
1.13
264
1293
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
27
22
12.82
27.40
2.0
1.3
ug/l
18.0
16.8
0.15
27
22
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
375
2380
2.62
26.93
9.8
5.4
mmol/l
1.2
1.2
7.26
332
2014
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
270
1483
2.53
26.19
3.7
2.2
u/l
56.4
57.5
0.12
252
1346
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
163
700
2.85
25.99
3.2
2.8
e6/l
4.4
3.7
0.25
87
360
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
257
1398
2.50
25.22
6.6
2.5
u/l
32.2
30.4
0.62
248
1334
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
171
771
2.73
24.68
3.2
2.6
e6/l
1.1
1.8
0.73
95
431
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
165
740
2.72
23.98
1.9
1.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
28
31
9.44
23.13
1.6
1.2
e6/l
10690.6
206005.7
0.49
14
18
(3002030) Lymphocytes/100 leukocytes in Blood
341
2164
2.39
23.04
7.0
5.6
%
25.2
27.9
3.20
323
1997
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
481
3598
2.96
22.52
17.4
5.2
u/l
93.7
75.6
6.27
469
3288
(3030467) Casts [#/volume] in Urine by Automated count
231
1247
2.42
22.47
3.6
3.0
e6/l
0.7
0.4
0.75
164
940
(3002582) Erythrocytes [#/volume] in Urine
243
1342
2.39
22.45
3.8
3.0
e6/l
22.0
110.6
1.12
180
1033
(36304419) Bacteria [Presence] in Urine
227
1219
2.42
22.31
3.6
2.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
334
2122
2.35
22.21
6.9
5.7
%
8.9
8.6
0.73
316
1965
(3023199) Leukocytes [#/volume] in Pleural fluid
29
36
8.43
21.94
1.6
1.2
e6/l
781.3
2049.8
1.33
21
25
(3018010) Neutrophils/100 leukocytes in Blood
334
2144
2.31
21.37
6.7
5.3
%
59.4
57.3
1.96
317
1988
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
74
224
3.64
21.00
10.8
9.6
mmol/l
24.6
24.8
0.19
74
204
(3006504) Eosinophils/100 leukocytes in Blood
329
2119
2.27
20.61
6.8
5.4
%
2.4
2.9
4.59
312
1948
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
125
522
2.78
20.57
1.9
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
322
2061
2.26
20.41
6.8
5.4
%
0.6
0.7
2.69
303
1897
(3019198) Lymphocytes [#/volume] in Blood
353
2351
2.28
20.25
7.3
5.3
e9/l
1.8
1.9
0.05
296
2045
(3001604) Monocytes [#/volume] in Blood
347
2295
2.27
20.24
7.1
5.2
e9/l
0.6
0.6
0.87
290
1965
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
124
521
2.75
20.14
1.9
1.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
348
2310
2.26
20.04
7.1
5.2
e9/l
0.0
0.0
2.97
289
1981
(3018095) Leukocytes [#/volume] in Urine
269
1610
2.25
19.97
6.0
3.5
e6/l
47.9
102.4
1.19
194
1120
(3031040) Bacteria [#/volume] in Urine by Automated count
433
3156
2.46
19.91
6.6
4.7
e6/l
287.0
3140.4
—
10
37
(3018418) pH of Serum or Plasma
242
1392
2.27
19.74
5.7
2.9
ph
7.4
7.4
1.10
43
235
(40768795) Lymph node Pathology biopsy report
18
13
14.26
19.43
1.1
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
352
2397
2.19
18.36
7.3
5.5
e9/l
0.2
0.2
2.58
299
2086
(3013826) Glucose [Moles/volume] in Serum or Plasma
392
2792
2.24
18.18
7.7
4.2
mmol/l
6.8
6.8
0.18
383
2597
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
411
4943
0.42
18.17
4.3
5.3
mmol/l
2.8
2.7
0.19
360
4495
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
178
930
2.32
17.96
5.6
2.2
mmol/l
2.5
2.4
7.36
161
800
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
398
4836
0.44
17.62
4.0
4.7
mmol/l
4.7
4.7
0.15
359
4400
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
393
4791
0.44
17.27
3.9
4.7
mmol/l
1.4
1.5
3.90
349
4345
(3045788) Cell count panel - Pleural fluid
23
29
8.22
17.13
1.6
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
128
601
2.45
16.28
2.6
2.3
%
20.8
23.0
1.08
109
512
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
373
4607
0.47
16.02
5.6
6.2
mmol/mol
41.1
40.2
1.03
343
4217
(3004789) Transferrin [Mass/volume] in Serum or Plasma
133
647
2.37
15.57
2.5
2.2
g/l
2.1
2.4
3.67
126
601
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
75
278
2.95
15.18
1.8
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
44
116
4.02
15.13
1.9
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
253
1606
2.02
14.90
3.8
3.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
138
717
2.21
13.66
2.6
2.2
umol/l
11.7
13.2
1.78
131
657
(3012441) Differential panel - Pleural fluid
20
29
7.11
13.21
1.7
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
176
1018
2.05
13.11
1.9
1.6
mg/l
2.3
1.1
3.05
152
791
(3003694) ABO and Rh group [Type] in Blood
183
1078
2.02
12.93
1.4
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
166
949
2.05
12.71
2.7
2.4
e6/l
7.5
6.6
0.36
143
833
(3002032) Base excess in Venous blood by calculation
93
425
2.41
12.35
4.0
3.5
mmol/l
1.9
2.2
0.34
80
345
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
389
4634
0.51
11.97
3.7
4.2
mmol/l
1.4
1.3
1.99
345
4154
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
412
4807
0.51
11.49
4.7
4.8
mmol/l
6.1
6.0
0.62
371
4320
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
11
11.12
11.09
3.8
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
73
315
2.51
10.93
6.6
4.6
—
—
—
0
0
(3035880) pH of Pleural fluid
14
18
7.95
10.18
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
22
6.97
9.77
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
64
276
2.48
9.58
1.6
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
147
891
1.87
9.11
2.6
2.6
mosm/kgh2o
483.3
532.7
1.97
115
751
(1761868) Lipid panel - Serum or Plasma
89
1571
0.49
8.96
2.8
3.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
20
43
4.78
8.88
2.4
3.3
%
2.8
1.6
0.45
15
35
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
153
952
1.82
8.67
3.5
4.0
ng/l
79.5
217.9
1.71
120
759
(3021589) Normoblasts [#/volume] in Blood
275
2020
1.69
8.63
13.0
8.2
e9/l
0.0
0.0
0.77
214
1634
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
393
4552
0.58
8.25
5.1
5.0
mu/l
2.1
2.2
0.27
355
4111
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
73
3.68
8.21
1.2
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
45
183
2.58
7.61
5.4
4.2
mmol/l
1.3
1.4
0.10
45
178
(3027945) Reticulocytes/100 erythrocytes in Blood
95
528
1.96
7.56
2.0
2.3
%
1.8
1.8
0.05
89
465
(3023520) Reticulocytes [#/volume] in Blood
78
408
2.05
7.34
1.5
2.6
e9/l
61.9
69.3
0.69
41
317
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
320
3861
0.62
7.30
4.7
4.1
pmol/l
14.7
14.9
1.23
294
3476
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
19
6.43
7.27
1.8
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
35
128
2.85
7.25
1.7
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
119
2.79
6.45
1.3
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
47
3.92
6.30
1.1
2.5
u/ml
—
377.4
—
0
5
(3011397) Hemoglobin [Presence] in Urine by Test strip
166
1151
1.62
6.07
7.4
3.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
370
1.98
6.06
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
173
1213
1.61
6.04
2.2
2.2
mg/l
2.7
3.1
1.87
147
1016
(3011412) CD3 cells [#/volume] in Blood
13
27
4.90
6.00
1.8
1.7
e9/l
0.6
1.6
—
7
14
(3020891) Body temperature
44
200
2.30
5.89
6.6
4.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
393
3330
1.56
5.73
8.1
4.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
53
3.47
5.34
3.7
2.1
u/l
7.3
135.4
—
6
18
(3021601) Nitrite [Presence] in Urine by Test strip
295
2374
1.49
5.32
9.6
5.2
estimate
0.0
0.0
0.50
49
418
(3022217) INR in Platelet poor plasma by Coagulation assay
104
660
1.70
5.30
15.2
26.4
inr
1.3
1.3
0.00
13
85
(3009261) Glucose [Presence] in Urine by Test strip
297
2395
1.49
5.30
7.0
3.9
estimate
0.0
0.0
0.00
49
413
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
20
64
3.20
5.23
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
232
2.12
5.17
1.2
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
75
439
1.81
5.05
2.1
3.1
ng/l
109.0
204.0
3.30
64
405
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
23
4.86
5.03
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
51
3.40
4.92
1.8
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
82
498
1.75
4.88
2.0
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
48
3.40
4.63
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
89
1340
0.60
4.61
1.5
1.6
mmol/l
1.4
1.4
0.44
72
1114
(3011648) Oxygen content in Venous blood
13
34
3.89
4.55
5.5
3.1
%
10.2
10.9
0.27
13
34
(3019230) Fractional oxyhemoglobin in Venous blood
21
77
2.79
4.39
5.2
2.4
%
62.4
62.6
0.02
21
77
(3024928) Oxygen saturation in Venous blood
24
95
2.59
4.35
4.9
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
138
984
1.53
4.31
5.8
4.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
889
0.54
4.31
1.2
1.3
u/ml
10.4
13.2
0.11
16
319
(3043410) Blood group antigens tested for on Red Blood Cells
8
9
8.99
4.29
2.8
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
12
31
3.93
4.27
1.2
1.3
nmol/l
0.6
0.4
—
5
25
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
31
3.93
4.27
1.1
3.0
%
56.5
50.9
—
6
22
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
36
3.67
4.22
2.9
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
76
471
1.71
4.21
4.5
2.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
71
432
1.73
4.20
4.4
3.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
92
2.56
4.09
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
71
436
1.72
4.07
1.4
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
34
163
2.15
4.06
4.1
2.0
ug/l
853.5
312.8
0.69
34
152
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
227
0.26
3.99
2.2
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
88
2.56
3.92
1.5
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
54
3.02
3.87
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
50
3.05
3.71
1.4
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
42
226
1.93
3.70
4.1
2.9
%
1.3
1.1
0.29
42
226
(3003327) Ova and parasites identified in Stool by Light microscopy
29
137
2.18
3.61
1.4
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
41
221
1.92
3.60
4.2
2.9
%
0.6
0.6
0.08
41
212
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
51
2.99
3.60
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
51
2.99
3.60
1.4
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
332
0.35
3.53
1.9
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
132
2.18
3.51
1.5
1.3
ug/g
209.7
314.9
1.76
20
77
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
87
2.47
3.51
1.4
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
72
463
1.63
3.48
2.7
2.5
ug/l
7.9
6.2
0.19
65
403
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
82
2.49
3.42
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
82
2.49
3.42
1.5
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
42
3.14
3.39
2.2
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
53
2.88
3.38
1.5
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
53
2.88
3.38
1.5
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
21
90
2.38
3.28
4.4
3.7
mmol/l
3.3
3.2
0.08
14
62
(44790047)
13
43
3.07
3.27
1.4
1.5
—
—
—
0
0
(44806118)
13
43
3.07
3.27
1.4
1.5
—
—
—
0
0
(44790048)
13
43
3.07
3.27
1.4
1.5
—
—
—
0
0
(44790049)
13
43
3.07
3.27
1.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
27
130
2.13
3.23
2.8
1.8
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
50
298
1.74
3.21
4.2
3.1
g/l
111.7
127.9
6.22
50
289
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
61
385
1.65
3.18
5.1
2.1
ml/min/173m2
56.2
64.4
1.20
26
156
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
85
2.40
3.18
4.9
3.2
%
60.7
58.8
0.29
20
85
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
338
2947
1.35
3.15
4.5
2.8
u/l
67.6
46.0
2.17
314
2700
(21494814) CD8 cells/100 lymphocytes in Specimen
6
8
7.56
3.06
2.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
23
107
2.20
3.00
1.1
1.1
titre
64.0
68.9
—
5
9
(3017181) Myelocytes/100 leukocytes in Blood
57
360
1.65
2.98
3.6
4.1
%
1.5
0.8
1.12
33
69
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
82
2.36
2.94
4.7
2.9
e9/l
4.1
4.4
0.27
19
82
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
185
1.89
2.94
1.4
1.6
g/l
2.3
1.6
2.50
28
162
(3000963) Hemoglobin [Mass/volume] in Blood
506
5302
0.65
2.94
54.2
18.7
g/l
120.5
134.2
64.62
495
5195
(3010813) Leukocytes [#/volume] in Blood
506
5302
0.65
2.94
53.8
18.6
e9/l
7.1
6.6
2.15
485
5114
(3026361) Erythrocytes [#/volume] in Blood
506
5301
0.65
2.91
53.7
18.6
e12/l
4.1
4.5
36.56
484
5114
(3035941) MCH [Entitic mass]
506
5301
0.65
2.91
53.5
18.5
pg
30.2
30.3
0.65
495
5195
(3024731) MCV [Entitic volume]
506
5300
0.65
2.89
53.5
18.5
fl
91.8
91.3
1.47
495
5194
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
96
2.23
2.86
1.4
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
506
5299
0.65
2.86
53.9
18.5
e9/l
269.0
252.2
4.56
488
5129
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
53
2.68
2.81
1.5
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
42
2.90
2.76
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
48
2.75
2.73
1.2
1.3
—
—
—
0
0
(4268621)
11
37
3.01
2.70
2.1
2.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
10
6.05
2.70
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
63
914
0.65
2.66
1.2
1.3
iu/ml
14.9
38.5
2.96
11
289
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
15
4.71
2.60
1.0
1.6
%
98.1
87.9
—
7
15
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
68
2.39
2.57
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
232
1.73
2.56
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
102
2.10
2.50
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
39
2.86
2.48
1.9
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
57
2.49
2.46
1.1
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
57
2.49
2.46
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
273
2361
1.29
2.46
7.3
3.9
estimate
0.0
0.0
0.00
50
424
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
12
5.04
2.40
4.0
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
176
1.80
2.39
2.2
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
22
3.67
2.37
3.5
2.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
522
0.59
2.24
1.5
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
176
2099
0.77
2.23
2.5
2.3
nmol/l
75.0
79.1
1.22
162
1831
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
190
1584
1.30
2.22
3.0
3.0
ng/l
1488.9
1337.1
0.21
170
1329
(4306422)
13
55
2.39
2.13
1.0
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
68
2.24
2.12
1.5
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
43
2.59
2.10
1.2
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
25
3.23
2.10
1.7
1.1
umol/l
26.5
30.9
—
8
25
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
10
5.03
2.07
1.4
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
56
0.00
2.07
0.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
56
2.35
2.06
1.5
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
20
3.53
2.06
5.9
1.4
u/l
221.0
201.1
—
7
20
(3014051) Protein [Presence] in Urine by Test strip
21
113
1.89
1.94
3.7
2.4
—
—
—
0
0
(1002224) Polysomnography panel
7
173
0.40
1.93
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
158
0.37
1.91
1.2
1.2
—
12.4
—
0
28
(3044889) 12 lead EKG panel
374
3424
1.26
1.91
4.3
3.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
500
4755
1.37
1.88
32.2
12.4
mg/l
42.0
22.2
24.13
478
3663
(1616796) Gas panel - Central venous blood
16
79
2.05
1.87
2.6
3.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
12
4.19
1.82
3.6
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
153
0.39
1.78
1.2
1.2
—
2.9
—
0
17
(3020682) Albumin/Creatinine [Ratio] in Urine
140
1678
0.78
1.77
3.4
3.9
mg/mmol
13.4
7.9
0.89
85
995
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
6
18
3.36
1.75
2.5
2.2
nmol/l
5.8
13.3
—
6
13
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
30
2.69
1.73
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
13
3.87
1.72
1.2
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
163
0.42
1.69
1.1
1.2
—
21.8
—
0
7
(3021440) Promyelocytes/100 leukocytes in Blood
49
344
1.46
1.68
3.7
4.2
%
0.3
0.1
1.36
29
61
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
19
3.18
1.66
1.3
1.1
u/l
44.2
21.3
—
6
14
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
31
2.60
1.66
1.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
187
0.47
1.64
3.3
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
166
1.66
1.64
2.1
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
131
0.38
1.64
1.0
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
20
3.02
1.58
1.3
1.1
u/l
91.3
80.7
—
6
15
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
42
0.00
1.53
0.0
1.2
—
1.3
—
0
20
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
125
0.39
1.51
1.0
1.2
—
10.7
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
21
2.88
1.51
1.3
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
155
1.64
1.49
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
155
1.64
1.49
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
35
237
1.51
1.45
1.2
1.4
g/l
1.0
1.2
0.95
29
220
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
16
3.14
1.44
1.2
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
22
2.74
1.43
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
157
1.62
1.43
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
94
756
1.29
1.42
1.3
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
29
2.43
1.39
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
41
2.21
1.37
2.4
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
141
1197
1.23
1.36
3.1
2.3
umol/l
336.6
6214.5
4.25
128
1001
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
50
666
0.73
1.36
4.1
5.0
%
31.6
33.1
0.37
35
415
(40768797) Stomach Pathology biopsy report
86
690
1.29
1.33
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
114
1.69
1.29
1.5
1.3
—
—
—
0
0
(4094501)
6
133
0.45
1.29
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
138
1.62
1.28
3.9
3.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
289
0.61
1.26
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
36
2.24
1.24
1.1
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
85
1038
0.79
1.24
1.7
1.7
nmol/l
1335.4
1230.7
0.40
66
750
(3051611) Lipemic interference index of Serum or Plasma
10
49
2.06
1.22
3.1
2.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
68
536
1.30
1.21
1.5
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
310
0.63
1.21
1.3
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
26
2.32
1.19
2.0
3.7
—
—
—
0
0
(3017704) Immunofixation for Urine
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3000492) Spirometry study
27
388
0.68
1.15
1.7
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
65
1.86
1.14
2.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
111
1.64
1.13
1.9
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
41
303
1.38
1.12
3.9
2.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
50
382
1.34
1.12
8.1
3.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
73
1.80
1.11
2.0
1.2
nmol/l
0.9
0.6
0.51
13
65
(3025159) Blasts/100 leukocytes in Blood
44
332
1.35
1.07
3.9
4.3
%
0.0
1.5
0.50
22
58
(3017732) Neutrophils [#/volume] in Blood
42
315
1.36
1.06
3.2
3.0
e9/l
4.5
4.0
0.61
36
229
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
123
0.48
1.06
1.2
1.2
—
40.6
—
0
12
(3027273) Bicarbonate [Moles/volume] in Venous blood
33
238
1.41
1.05
3.1
3.1
mmol/l
25.5
25.5
0.01
33
228
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
230
1.41
1.04
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
61
1.82
0.99
1.4
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
23
2.18
0.98
1.2
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
23
2.18
0.98
1.2
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
208
1.41
0.96
3.6
5.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
37
1.90
0.94
1.1
1.2
—
—
—
0
0
(3036603) Volume of Urine
6
27
2.23
0.93
1.2
1.6
—
2063.4
—
0
7
(40761511) CBC panel - Blood by Automated count
482
4966
0.83
0.93
28.1
12.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
52
1.74
0.92
1.9
2.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
63
1.76
0.90
2.2
1.2
nmol/l
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
63
1.76
0.90
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
29
211
1.39
0.90
3.3
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
147
1303
1.17
0.90
7.8
4.1
estimate
0.0
0.0
0.50
50
411
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.5
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
128
0.54
0.89
1.6
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
141
1584
0.85
0.88
2.8
3.1
mg/l
312.0
251.5
0.08
87
945
(3002179) Metamyelocytes/100 leukocytes in Blood
43
337
1.30
0.84
3.6
4.1
%
1.2
0.4
1.28
18
55
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.84
1.8
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
500
5125
0.83
0.84
24.7
9.0
u/l
25.0
24.2
0.58
486
4891
(3021788) Differential panel - Synovial fluid
6
111
0.54
0.84
1.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
97
1.56
0.82
1.3
1.2
—
—
—
0
0
(3013512) EKG study
133
1493
0.86
0.82
4.3
3.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
58
1.74
0.80
1.2
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
24
0.00
0.79
0.0
1.2
—
6.0
—
0
24
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
25
182
1.39
0.79
3.8
6.2
mmol/l
24.9
24.8
0.03
25
172
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
34
1.77
0.76
1.0
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
46
370
1.26
0.76
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
24
2.09
0.74
1.6
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
55
1.65
0.73
1.4
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
149
1646
0.87
0.73
2.6
3.1
mmol/l
6.3
6.8
0.78
117
1362
(3022806) Fractional oxyhemoglobin in Capillary blood
9
57
1.59
0.71
1.8
1.7
%
91.7
89.9
—
9
57
(3023511) Choriogonadotropin [Units/volume] in Urine
7
41
1.72
0.70
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
27
1.86
0.68
1.4
2.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
34
428
0.78
0.68
1.4
1.6
%
1.6
1.5
0.26
28
370
(3001019) Free T4 and TSH panel - Serum or Plasma
12
179
0.66
0.67
1.0
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
57
478
1.21
0.66
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
44
1.60
0.65
1.3
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
257
0.73
0.64
1.5
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
65
557
1.19
0.61
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
289
0.75
0.61
1.6
1.8
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
21
0.00
0.60
0.0
1.2
—
36.5
—
0
12
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
12.9
—
877.8
—
0
21
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
21.4
—
1649.5
—
0
22
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
87
0.57
0.56
1.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
60
1.51
0.54
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
438
4498
0.89
0.54
35.6
11.3
ml/min/173m2
78.1
76.8
0.65
405
3595
(3001122) Ferritin [Mass/volume] in Serum or Plasma
215
2017
1.10
0.54
2.8
2.6
ug/l
219.6
109.0
5.70
199
1825
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
268
1.25
0.54
3.6
5.2
mmol/l
1.5
1.8
0.18
28
208
(3021960) Folate [Moles/volume] in Serum or Plasma
136
1245
1.12
0.53
1.6
1.5
nmol/l
20.3
21.7
0.51
123
1044
(3019832) Treponema pallidum Ab [Presence] in Serum
19
247
0.76
0.51
1.2
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
119
1088
1.12
0.48
6.6
4.3
kg/l
1.0
1.0
0.37
17
159
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
203
2153
0.91
0.47
2.0
2.0
pmol/l
87.4
96.7
2.16
120
1037
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
250
2623
0.92
0.46
2.8
2.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
7
50
1.40
0.45
1.1
1.0
—
2.3
—
0
22
(4024509)
7
51
1.38
0.44
2.4
1.5
—
—
—
0
0
(4034850)
13
174
0.74
0.44
8.0
9.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
70
783
0.88
0.43
3.4
3.6
%
25.0
24.4
0.05
30
363
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
151
0.72
0.43
1.6
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
92
0.65
0.42
1.0
1.5
—
—
—
0
0
(4010399)
32
380
0.83
0.42
1.3
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
10
70
1.44
0.42
1.1
1.3
mu/l
323.1
51.7
—
10
59
(44813793)
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(4015189)
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
287
1.20
0.41
2.2
2.5
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
91
995
0.90
0.40
4.0
3.8
ug/l
2.2
2.1
0.14
78
872
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
61
1.32
0.39
1.0
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
205
1947
1.08
0.38
4.0
3.7
ng/l
26.3
52.0
0.81
161
1391
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
68
1.33
0.37
1.2
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
158
0.75
0.37
1.0
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
22
180
1.23
0.36
1.4
1.6
—
107.5
—
0
8
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
28
236
1.20
0.35
1.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
191
1.21
0.34
2.5
1.3
g/l
3.8
3.8
0.03
18
133
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
191
1.21
0.34
2.5
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
191
1.21
0.34
2.5
1.3
g/l
8.4
7.6
0.63
18
137
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
12
155
0.77
0.33
1.9
1.7
g/l
0.2
0.2
0.01
12
149
(3009445) Proteinase 3 Ab [Units/volume] in Serum
26
219
1.20
0.33
1.1
1.6
—
14.5
—
0
6
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
87
0.69
0.33
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
47
1.28
0.32
1.3
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
193
1841
1.07
0.32
6.6
4.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
119
1.27
0.32
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
267
1.17
0.32
3.6
3.9
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7
54
1.30
0.30
1.1
1.3
—
120.1
—
0
8
(3007164) IgA [Mass/volume] in Serum or Plasma
93
864
1.09
0.30
1.6
1.3
g/l
2.7
2.5
0.20
57
491
(3004588) Protein electrophoresis panel - Serum or Plasma
29
334
0.86
0.29
2.1
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
63
1.27
0.28
1.6
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
63
1.27
0.28
1.1
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
161
0.80
0.27
1.8
1.7
g/l
1.2
1.2
0.38
13
152
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
73
0.68
0.26
6.0
4.3
umol/l
385.6
365.1
—
5
62
(3021901) Oxygen saturation in Capillary blood
9
73
1.24
0.25
4.3
2.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.0
—
1.0
—
0
8
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
12
0.00
0.21
0.0
1.2
—
2.0
—
0
12
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
50
541
0.92
0.20
2.5
2.6
ug/l
0.6
0.8
1.57
34
358
(3039443) Prostate specific Ag panel - Serum or Plasma
6
48
1.25
0.20
1.8
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
15
127
1.19
0.19
1.7
1.2
g/l
0.0
0.0
0.00
15
116
(3013707) Erythrocyte sedimentation rate by Westergren method
374
3678
1.05
0.19
3.6
4.3
mm/h
22.1
12.6
9.68
337
3372
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
51
1.18
0.19
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
53
492
1.08
0.19
4.7
3.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
11
90
1.23
0.19
1.7
2.3
umol/l
33.4
33.3
0.00
11
79
(3023410) Appearance of Cerebral spinal fluid
6
52
1.16
0.19
1.7
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
29
320
0.90
0.17
1.1
1.2
iu/ml
35.2
127.1
—
7
133
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
101
1057
0.95
0.17
1.2
1.2
u/ml
0.7
2.1
1.86
21
288
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
16
138
1.16
0.17
2.1
1.3
g/l
1.2
0.0
0.57
16
124
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
82
1.22
0.17
7.6
2.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
12
101
1.19
0.16
1.7
1.8
g/l
121.7
130.8
—
7
73
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
15
130
1.16
0.15
1.7
1.2
g/l
0.2
0.0
0.74
15
117
(3037756) Immunofixation for Serum or Plasma
7
87
0.80
0.14
1.3
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
12
139
0.86
0.14
2.3
1.3
mg/l
37.5
40.9
0.14
12
115
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
12
139
0.86
0.14
2.3
1.3
mg/l
31.0
30.4
0.03
12
115
(40760888) Immunoglobulin light chains.free panel - Serum
8
100
0.80
0.13
2.6
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
128
1245
1.04
0.11
5.8
3.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
12
105
1.15
0.11
4.3
7.0
kpa
8.3
8.1
0.13
12
98
(1761482) Bacteria [#/volume] in Urine by Culture
12
136
0.88
0.11
2.6
5.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
125
1.12
0.10
1.6
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
10
87
1.15
0.09
1.9
1.4
mu/l
306.4
315.4
—
10
78
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
70
675
1.04
0.09
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
349
0.94
0.09
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
67
1.05
0.08
1.0
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
71
0.84
0.07
2.3
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
71
0.84
0.07
2.2
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
68
659
1.04
0.07
1.2
1.3
titre
537.1
601.2
0.12
14
165
(3020961) Endomysium IgA Ab [Titer] in Serum
19
204
0.93
0.07
1.0
1.1
—
149.0
—
0
9
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
157
1595
0.98
0.06
2.6
2.1
u/l
122.5
197.8
2.48
151
1496
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
104
0.86
0.06
1.3
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
14
129
1.09
0.05
2.4
2.3
mg/l
11.2
12.9
0.36
14
117
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
151
0.93
0.05
1.2
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
112
1139
0.98
0.05
1.8
1.7
pmol/l
126087421.6
6572189.4
0.46
92
913
(3003338) MCHC [Mass/volume]
398
3962
1.01
0.04
51.1
16.7
g/l
328.0
331.7
15.35
392
3932
(3023103) Potassium [Moles/volume] in Serum or Plasma
503
5044
0.98
0.04
40.0
15.2
mmol/l
4.0
4.0
0.20
492
4883
(3048689) Calprotectin [Mass/mass] in Stool
56
550
1.02
0.02
1.9
2.0
ug/g
99.1
144.2
0.74
45
432
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
178
0.95
0.02
1.6
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
104
1.06
0.01
1.4
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
123
0.98
0.00
1.7
1.7
iu/l
3.5
5.8
—
5
44
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
20
202
0.99
0.00
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
424
4243
1.00
0.00
40.2
14.0
%
35.9
39.4
13.06
303
2801
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
70
698
1.00
0.00
16.0
6.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
503
5032
1.00
0.00
40.0
15.1
mmol/l
138.6
139.7
15.26
492
4883
(40768443) Skin Pathology biopsy report
18
179
1.01
0.00
1.3
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
51
0.98
0.00
39.6
4.1
mmol/l
7.6
7.7
—
5
41
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
67
0.89
0.00
2.0
2.3
mmol/l
103.2
105.3
—
6
67
(3016018) Differential panel - Cerebral spinal fluid
5
49
1.02
0.00
1.4
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
67
0.89
0.00
2.0
2.3
mmol/l
4.3
4.1
—
6
67
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
51
0.98
0.00
2.6
3.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
65
0.92
0.00
2.0
2.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
92
0.98
0.00
1.1
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
59
1.02
0.00
1.2
2.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
88.0
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RETROPERITONEUM_PERITONEUM_EXALLC – Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).